Eurosurveillance banner


Eurosurveillance invites authors to submit papers for a special issue on HIV/AIDS and other sexually transmitted infections (STI) in men who have sex with men (MSM). The topic is in line with the main theme of World AIDS Day 2009 events organised by the European Centre for Disease Prevention and Control and aims at drawing attention to the epidemiological importance of MSM in HIV and other STI and directing the ECDC activities to focus on main risk groups.

Eurosurveillance is planning to publish a special issue on Socio-economic determinants and infections diseases in Europe in spring 2010. For this reason Eurosurveillance invites interested scientists who have research findings in the area to submit papers for review and possible publication. The submission deadline now is 15 November.

The data from 27 European Union countries plus Iceland, Liechtenstein and Norway show that considerable progress has been made in preventing and controlling the disease. The number of newly diagnosed cases and the overall notification rate declined continuously in the past decade, and the notification rate in 2007 was 12% lower than in 2003. In spite of this decline, a total of 84,917 new cases of TB were registered in 2007 and a number of challenges hamper the progress towards the elimination of TB in the EU.

A number of bacterial and viral infections in pregnant women can have serious effects on the unborn child leading to impaired mental and physical health later in life. This week’s issue of Eurosurveillance is dedicated to infectious diseases in pregnancy.

The emergence and spread of antimicrobial resistance (AMR) is a growing problem in many European countries. To mark the very first European Antibiotic Awareness Day, on 18 November, the scientific journal Eurosurveillance runs a series of articles to highlight main aspects of the AMR problem in Europe. They will be published in two issues on 13 and 20 November 2008.

In preparation for the coming influenza season 2008-9, Eurosurveillance publishes a special issue on prevention of influenza by vaccination. Seasonal influenza poses a serious public health threat because of associated serious morbidity and mortality. In Europe, estimates suggest that influenza is responsible for around 40,000 to 220,000 excess deaths, depending on the severity of the epidemic.

Today Eurosurveillance is publishing a special issue dedicated to the widespread advances made in Europe in estimating the real number of newly acquired HIV infections based on an innovative approach called STARHS

To tie in with World Hepatitis Day on 19 May, the scientific journal Eurosurveillance is today publishing a special issue on viral hepatitis, highlighting issues and challenges related to hepatitis B and C.

On 17 April 2008, Eurosurveillance is publishing a special issue with articles on the measles situation in Europe. The publication is linked to European Immunisation Week which runs from 21-27 April.

World Tuberculosis Day on 24 March commemorates the date in 1882 when Robert Koch presented his findings of the causing agent of tuberculosis (TB) – Mycobacterium tuberculosis. In the run up of this day Eurosurveillance publishes a special issue on the situation of TB in Europe.

Today (6 March, 2008), Eurosurveillance, the European peer-reviewed journal of infectious diseases, publishes a special issue on meningococcal disease. It includes two in-depth articles and an editorial by the European Centre for Disease Prevention and Control (ECDC).


Eurosurveillance Quartely Q2 2009


Eurosurveillance, the European scientific journal devoted to the epidemiology, surveillance, prevention and control of communicable diseases, has been selected for coverage by Thomson Reuters and is indexed and abstracted in the Science Citation Index Expanded (also known as SciSearch®) and in the Journal Citation Reports/Science Edition beginning with Volume 14 (1) 2009. The first official Impact Factor is expected to be allocated in 2011, after the two-year evaluation period.


In this issue:
Five reviews on arthropod-borne diseases transmitted by mosquitoes and phlebotomine sandflies


Eurosurveillance, Volume 15, Issue 10, 11 March 2010

Table of Contents

Editorials

A perspective on emerging mosquito and phlebotomine-borne diseases in Europe
Review articles

West Nile virus in Europe: understanding the present to gauge the future
The appearance of West Nile virus in New York in 1999 and the unprecedented panzootic that followed, have stimulated a major research effort in the western hemisphere and a new interest in the presenc(...)
Yellow fever and dengue: a threat to Europe?
The introduction and rapidly expanding range of Aedes albopictus in Europe is an iconic example of the growing risk of the globalisation of vectors and vector-borne diseases. The history of yellow fev(...)
Rift Valley fever - a threat for Europe?
Rift Valley fever (RVF) is a severe mosquito-borne disease affecting humans and domestic ruminants, caused by a Phlebovirus (Bunyaviridae). It is widespread in Africa and has recently spread to Yemen (...)
Leishmaniasis emergence in Europe
Leishmaniasis emergence in Europe is reviewed, based on a search of literature up to and including 2009. Topics covered are the disease, its relevance, transmission and epidemiology, diagnostic method(...)
Arthropod-borne viruses transmitted by Phlebotomine sandflies in Europe: a review
Phlebotomine sandflies are known to transmit leishmaniases, bacteria and viruses that affect humans and animals in many countries worldwide. These sandfly-borne viruses are mainly the Phlebovirus, the(...)
Perspectives

Crimean-Congo hemorrhagic fever in Europe: current situation calls for preparedness
During the last decade Crimean-Congo hemorrhagic fever (CCHF) emerged and/or re-emerged in several Balkan countries, Turkey, southwestern regions of the Russian Federation, and the Ukraine, with consi(...)

Disclaimer:The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the Editorial team or the institutions with which the authors are affiliated. Neither the ECDC nor any person acting on behalf of the ECDC is responsible for the use which might be made of the information in this journal.
The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our Website does not host any form of commercial advertisement.

Eurosurveillance [ISSN] - ©2008 All rights reserved
 

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.